All In Biotech

Free tool

FAERS Monitor: Tindamax

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021618 or its brand name (Tindamax, Tinidazole). Reports on generic versions are filed under their own applications.

Reports

435

Serious

314

72% of reports

Hospitalization

127

Death reported

20

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective33
  • nausea28
  • off label use26
  • pruritus26
  • headache25
  • diarrhoea22
  • vomiting22
  • pyrexia21
  • rash21
  • anxiety20
  • neuropathy peripheral19
  • paraesthesia19
  • pain17
  • dizziness15
  • dyspnoea13

Reports by year received

View as table
YearReports
20058
20063
20074
20085
200910
201011
201116
201218
201318
201425
201521
201631
201718
201827
201938
202049
202131
202224
202334
202412
202524
20268

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,724 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
neuropathy peripheralSignal199.76.2140
paraesthesiaSignal195.83.872
anxietySignal203.42.232
pruritusSignal263.32.339
pyrexiaSignal212.91.925
rashSignal212.31.515
vomitingSignal222.31.515
headache251.91.311
nausea281.71.28
diarrhoea221.61.15
dizziness151.50.92
off label use261.41.03
pain171.30.81
drug ineffective331.20.91
dyspnoea131.10.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.